Prediabetes has traditionally been diagnosed during annual physical exams through fasting glucose tests or A1C measurements. However, new diabetes prevention tools and wearable technologies are rapidly changing that model. Today, wearable devices, continuous glucose monitors (CGMs), and predictive metabolic tracking tools are giving people real-time insight into their glucose patterns …
Read More »GLP-1 Therapy and Visit Frequency: Do Patients Need Less Follow-Up—or More?
As GLP-1 receptor agonists become a cornerstone of diabetes care, clinicians are rethinking how often patients on GLP-1 therapy need follow-up visits. These therapies often deliver improved glycemic control, weight loss, and cardiovascular benefits. However, does this stability mean fewer clinic visits, or does it require closer monitoring in new …
Read More »Using Time in Range to Adjust Therapy: A Practical Guide for Clinicians
The clinical use of time in range is changing how clinicians approach diabetes management. Instead of focusing only on A1C, many providers now rely on continuous glucose monitoring data to guide daily decisions. But how do you translate numbers into action? Think of it like a GPS for glucose control. …
Read More »CGM in Primary Care: Bridging the Endocrinology Gap
Could continuous glucose monitoring (CGM) soon become the norm in primary care? Once considered a specialty tool reserved for endocrinologists, CGM is now recommended far earlier in diabetes treatment — even for patients with type 2 diabetes on basal insulin alone. Despite these guideline shifts, primary care adoption has lagged. …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.